Nice.
Their 2024/25 revenue forecasts a little lighter versus my expectations, but I like the 2026 jump, now that is inkeeping with mine:
...and their gross profit forecasts for 2026 massive (the synergies between Remplir, Striate and SmartGrft production obvious) and a nice $15 million free cash flow call for 2026:
I've said I see OCC going (slightly) cash flow positive in 2025 for a long time now, and these guys are similarly forecasting a strong jump thereafter in cash flow in 2026. This is why I am similarly very confident on OCC post the BH/HS Striate deal and Remplir revenues going cash flow positive well before their $23 million cash buffer gets eroded, whilst getting there in 2024/25.
Petra forecasts figures do NOT include SmartGrft figures, but they obviously see those coming in post 2026 anyway in any meaningful fashion with US commercial entry then (a year after Remplir):
"Our forecasts do not include any value for the SmrtGraft Tendon product at this stage. As such, the tendon opportunity represents an upside to our valuation."
Nice to get some extra coverage beyond Veritas irresepective, who could do with updating.
Nice.Their 2024/25 revenue forecasts a little lighter versus my...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
-0.005(1.20%) |
Mkt cap ! $85.92M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 41.5¢ | 41.0¢ | $33.21K | 80.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16462 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 15000 | 1 |
View Market Depth
| Last trade - 10.44am 02/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |